|
Strategy-Launch and Pre-Launch Clinical Trials
Diabetes: Low Blood Glucose Levels Do Not Explain Excess Deaths in ACCORD TrialDate:
06/09/2009
, Publication:
ADA
, Author:
American Diabetes Association
http://www.diabetes.org/for-media/pr-accord-trial.jsp
Head-Neck Cancer: Genmab Announces Partial Clinical Hold on Zalutumumab StudiesDate:
06/04/2009
, Publication:
PharmaLive
, Author:
PharmaLive
http://www.pharmalive.com/News/index.cfm?articleid=631583
Breast Cancer: Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast CancerDate:
06/01/2009
, Publication:
PharmaLlive
, Author:
BUSINESS WIRE
http://www.pharmalive.com/News/index.cfm?articleid=630805
Pfizer Offers Free Drugs to Unemployed, UninsuredDate:
05/14/2009
, Publication:
PharmaLive.com
, Author:
TherapeuticsDaily.com
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1916150&contentT
Rheumatoid Arthritis: A Phase IIb Study Testing the Combination of Methotrexate and CF101 in Rheumatoid Arthritis Patients Failed to Achieve Primary Efficacy EndpointDate:
04/30/2009
, Publication:
PharmaLive.com
, Author:
Business Wire
http://pharmalive.com/news/index.cfm?articleID=622883&categoryid=9&newsletter=1
FDA 101: Clinical Trials and Institutional Review BoardsDate:
04/29/2009
, Publication:
Consumer Update
, Author:
FDA
http://www.fda.gov/consumer/updates/clinicaltrials041409.html
Patrick Administration Passes Tough New Rules Governing Pharmaceutical and Medical Device IndustriesDate:
03/13/2009
, Publication:
Dail Advantage
, Author:
Pharmalive.com
http://pharmalive.com/news/index.cfm?articleID=611741&categoryid=9&newsletter=1
Prostate Cancer: FDA Approves Drug for Patients with Advanced Prostate Cancer
These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer.
Date:
12/29/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01935.html
Gastrointestinal Cancer: FDA Approves Gleevec to Prevent Recurrence of Rare Gastrointestinal Cancer
GIST is a fairly rare form of cancer that originates in cells found in the wall of the GI tract...
Date:
12/19/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01931.html
Bone Marrow Transplants: FDA Approves Drug that Boosts Stem Cell Yield for Bone Marrow Transplants
Mozobil is intended to be used in combination with the growth factor granulocyte-colony stimulating factor (G-CSF), for treatment of adults with multiple myeloma or non-Hodgkin’s lymphomas...
Date:
12/18/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01929.html
Previous
Page 1 of 21
Next >
Search returned 202 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|